The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices

Cardiome Pharma Corp closed at $2.27.

Over the last five days, shares have lost 9.20% and sit 1.34% above their 52-week low. This security has underperformed the S&P TSX by 50.05% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$1.04
Updated October 20 3:18 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-110.81%

Although this company's net profit margin is negative, it is above the industry average and implies that Cardiome Pharma Corp is operating more effectively than other companies in the industry.
Company Books

S&P TSX0.25%Sector:HealthcareIndustry:Biotechnology

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue6575
Total other revenue--------
Total revenue6575
Gross profit4454
Total cost of revenue2221
Total operating expense1211129
Selling / general / administrative10897
Research & development----00
Depreciation / amortization1111
Interest expense (income), net operating--------
Unusual expense (income)0--00
Other operating expenses, total--------
Operating income-6-5-5-4
Interest income (expense), net non-operating-1-1-1-1
Gain (loss) on sale of assets--------
Other--------
Income before tax-9-6-6-5
Income after tax-9-6-6-5
Income tax, total0000
Net income-9-6-6-5
Total adjustments to net income--------
Net income before extra. items-9-6-6-5
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-9-6-6-5
Inc. avail. to common incl. extra. items-9-6-6-5
Diluted net income-9-6-6-5
Dilution adjustment--------
Diluted weighted average shares32323228
Diluted EPS excluding extraordinary itemsvalue per share-0.26-0.20-0.18-0.19
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share-0.26-0.20-0.18-0.19